IBS-D (Diarrhea-predominant)
5 clinical trials · Condition
◉ Watch IBS-D (Diarrhea-predominant)
| Record | Firm | Date |
|---|---|---|
| Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndrome (NCT07574320) | Md. Aminul Islam | 2026-04-30 |
| Efficacy of Rifaximin With NAC in IBS-D (NCT06727422) | Mark Pimentel, MD | 2026-02-04 |
| Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome (NCT07168434) | Biocodex | 2025-10-22 |
| Study to Evaluate the Treatment Benefits of Probiotic Clostridium Butyricum CBM588® for IBS-D (NCT06676514) | Liaquat University of Medical & Health Sciences | 2024-11-10 |
| Bacillus Coagulans Based Product in IBS-Diarrhea (NCT07520422) | Bioagile Therapeutics Pvt. Ltd. | 2023-02-25 |
Track IBS-D (Diarrhea-predominant) automatically
Every clearance here is in the API, with alerts when new ones post.